Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-17

Clinical Trial Update: Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of N-acetylcysteine on beta-cell function in Type 2 diabetes mellitus; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Utzschneider, Kristina, M.D. | Conditions: Type 2 Diabetes, Oxidative Stress | NA | Status: COMPLETED | Results posted: 2016-06-17